Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics

Abstract

AbstractPorcine reproductive and respiratory syndrome (PRRS) is a respiratory disease in pigs that causes severe economic losses. Currently, live PRRSV vaccines are commonly used but fail to prevent PRRS outbreaks and reinfection. Inactivated PRRSV vaccines have poor immunogenicity, making PRRSV a significant threat to swine health globally. Therefore, there is an urgent need to develop an effective PRRSV vaccine. This study used immunoinformatics to predict, screen, design and construct a candidate vaccine that fused B‐cell epitopes, CTL‐ and HTL‐dominant protective epitopes of PRRSV strain's GP3 and GP5 proteins. The study identified 12 B‐cell epitopes, 6 CTL epitopes and 5 HTL epitopes of GP3 and GP5 proteins. The candidate vaccine was constructed with 50S ribosomal protein L7/L1 molecular adjuvant, which has antigenicity, solubility, stability, non‐allergenicity and a high affinity for its target receptor, TLR‐3. The C‐ImmSim immunostimulation results showed significant increases in cellular and humoral responses (B cells and T cells) and production of TGF‐β, IL‐2, IL‐10, IFN‐γ and IL‐12. The constructed vaccine was stable and immunogenic, and it can effectively induce strong T‐cell and B‐cell immune responses against PRRSV. Therefore, it is a promising candidate vaccine for controlling and preventing PRRSV outbreaks.